Matthew Elliot

Matthew Elliot

Neurosurgical Clinical Research Fellow and PhD Student

King's College London, United Kingdom

King's College Hospital NHS Foundation Trust, United Kingdom

Matthew is currently a Neurosurgery Clinical Research Fellow and PhD Student within the School of Biomedical Engineering & Imaging Sciences at King’s College London. His primary focus is with the q-FHSI (quantitative fluorescence in hyperspectral imaging) project funded by the Wellcome Trust. This project aims to work towards the validation of quantitative detection of 5-ALA fluorescence in glioma surgery through the use of hyperspectral imaging. This work then aims to integrate this technology into the surgical workflow to allow the use of real-time quantitative fluorescence information in low grade glioma surgery – adding a crucial adjunct to the intra-operative imaging available to the operating surgeon to improve patient outcomes.

Matthew commenced his medical degree at the University of Cambridge in 2009, graduating in 2015. As part of his undergraduate education he undertook an intercalated BA(cantab) in Natural Sciences (Neuroscience) for which he was awarded a first class degree. Following his undergraduate training he was appointed to the academic foundation programme at the University of Liverpool and Walton Centre NHS foundation trust. In this role, alongside his clinical foundation training he worked under the supervision of Professor Michael Jenkinson qualitatively assessing patient priorities in the treatment of low grade glioma. In 2017 Matthew was appointed to the national neurosurgical training programme and completed his core and intermediate neurosurgical training at Imperial College Healthcare, Barking Havering and Redbridge University Hospital and the National Hospital for Neurology and Neurosurgery. He was appointed as a member of the Royal College of Surgeons in 2018. In 2022 he began an out of programme research fellowship following his appointment as Clinical Research Fellow with the CAI4CAI group under the supervision of Jonathan Shapey and Tom Vercauteren.

  • Neurosurgery
  • Neuro-oncology
  • Neuro-imaging
  • Hyperspectral Imaging